Copyright
©2012 Baishideng Publishing Group Co.
World J Radiol. Nov 18, 2012; 4(11): 443-449
Published online Nov 18, 2012. doi: 10.4329/wjr.v4.i11.443
Published online Nov 18, 2012. doi: 10.4329/wjr.v4.i11.443
Figure 1 X-ray computed tomography images before radiotherapy and external beam radiotherapy treatment plan.
A: A lesion typical of internal mammary lymph node metastasis is observed, with no skin involvement; B: External beam therapy plan on the same slice. Subdermal dose at depth of 5 mm, epidermal dose, and dermal dose at depth of 2.5 mm was 57.1 Gy, 40 Gy and 48 Gy EQD2, α/β = 3, respectively, and 8-9.3 Gy (17.6-22.9 Gy-EQD2, α/β = 3). Isodose curves are 98% and 90% to 10% at intervals of 10% of 60 Gy, from innermost to outermost. White arrows: Positional markers for external beam radiotherapy simulation.
- Citation: Kishi K, Tanino H, Sonomura T, Shirai S, Noda Y, Sato M, Okamura Y. Novel eradicative high-dose rate brachytherapy for internal mammary lymph node metastasis from breast cancer. World J Radiol 2012; 4(11): 443-449
- URL: https://www.wjgnet.com/1949-8470/full/v4/i11/443.htm
- DOI: https://dx.doi.org/10.4329/wjr.v4.i11.443